You are here: Industry Insights > mRNA

News List

mCureX and Samyang sign MoU for mRNA vaccine development pharmaceutical-technology
June 08, 2021
OliX Pharmaceuticals’ subsidiary mCureX has entered a memorandum of understanding (MoU) with Samyang Holdings to develop a messenger ribonucleic acid (mRNA) vaccine for Covid-19.
Samsung Biologics expands portfolio with mRNA vaccine manufacturing capability cphi-online
June 03, 2021
The additional manufacturing suite at the CDMO's Songdo site is anticipated to be ready for cGMP operations within the first half of 2022
Biological E to produce Providence Therapeutics’ mRNA COVID-19 vaccine in India expresspharma
June 03, 2021
Biological E has entered into an agreement with Canada-based Providence Therapeutics Holdings, to manufacture the latter’s mRNA (messenger Ribonucleic acid) vaccine PTX-COVID19-B in India.
BREAKING NEWS: Researchers may know the cause for COVID-19 vaccine related blood clots europeanpharmaceuticalreview
May 31, 2021
Investigators at the Goethe University of Frankfurt believe that post-transcriptional modifications may be causing the clotting problems associated with recombinant vector COVID-19 vaccines.
Merck launches synthetic cholesterol product to meet high demand for lipids expresspharma
May 31, 2021
This neutral lipid, used in commercially marketed products, is more than 99 per cent pure; offers high batch-to-batch consistency and is scalable under commercial GMP.
COVID-19 vaccination now available for pregnant women between 14 and 36 weeks firstwordpharma
May 31, 2021
Pregnant women between 14 and 36 completed weeks gestation are now being offered an mRNA vaccine (Pfizer or Moderna), following a recent NIAC recommendation.
Moderna and Aldevron Announce Expanded Partnership for mRNA Vaccine and Therapeutic Pipeline americanpharmaceuticalreview
May 28, 2021
Moderna a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, and Aldevron, LLC, the leading provider of high-quality plasmid DNA, mRNA and recombinant proteins necessary for vaccines, gene and cell therapy, gene editing ...
COVID-19 mRNA vaccines are immunogenic in pregnant and lactating women worldpharmanews
May 19, 2021
Pregnant women with symptomatic COVID-19 have a higher risk of intensive care unit admissions, mechanical ventilation and death compared to non-pregnant reproductive age women.
mRNA COVID-19 vaccination is immunogenic in the immunocompromised europeanpharmaceuticalreview
May 19, 2021
Research suggests patients who receive COVID-19 vaccines prior to a transplant and subsequent immunosuppression may be protected from the disease.
BioNTech to Establish Regional HQ and Mfg. Facility in Singapore contractpharma
May 11, 2021
New manufacturing site will support global supply of mRNA-based vaccines and therapeutics.

Previous page 1 2 3 4 5 6 7 8 9 10 11 12 Next page